01-10-1998 | ORIGINAL ARTICLE
Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells
Published in: Cancer Immunology, Immunotherapy | Issue 3/1998
Login to get access01-10-1998 | ORIGINAL ARTICLE
Published in: Cancer Immunology, Immunotherapy | Issue 3/1998
Login to get access